source
- Veradermics reports positive Phase 2/3 results for oral Rogaine in men with pattern hair lossVeradermics, a biotech that recently went public, announced that its oral formulation of Rogaine met the primary endpoints in a late-stage Phase 2/3 trial. The study enrolled men with mild-to-mode…
- Veradermics reports positive late-stage results for oral hair-loss pill VDPHL01Veradermics announced that its experimental oral medication VDPHL01 met its primary goals in a Phase 3 trial for male pattern hair loss. Over six months, participants taking the drug once or twice…